Idenix Pharmaceuticals to Present at Credit Suisse First Boston's Healthcare Conference
November 08 2005 - 7:30AM
PR Newswire (US)
CAMBRIDGE, Mass., Nov. 8 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that
Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief
executive officer, will present a corporate overview at the
upcoming Credit Suisse First Boston Healthcare Conference on
Wednesday, November 16, 2005 at 10:30 a.m. at the Arizona Biltmore
in Phoenix. The live and archived webcast of the presentation can
be accessed under "Events" in the Idenix Investor Center at
http://www.idenix.com/. The archived replays will be available on
the Idenix website for two weeks following the presentations. About
Idenix Idenix Pharmaceuticals, Inc. is a biopharmaceutical company
engaged in the discovery and development of drugs for the treatment
of human viral and other infectious diseases. Idenix's current
focus is on the treatment of infections caused by hepatitis B
virus, hepatitis C virus and human immunodeficiency virus (HIV).
Idenix's headquarters are located in Cambridge, Massachusetts and
it has drug discovery operations in Montpellier, France and
Cagliari, Italy. Contact: Idenix Pharmaceuticals, Inc. Teri Dahlman
(617) 995-9905 DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT:
Teri Dahlman of Idenix Pharmaceuticals, Inc., +1-617-995-9905 Web
site: http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals (MM) News Articles